OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Credit Tracker

Quick Links

Weekly Credit Tracker

Credit ratings are not currently available for public cannabis companies leaving companies, lenders and investors with a gap of information. The Viridian Cannabis Credit Tracker fills this gap. The model uses 11 market and financial statement variables to discern 4 key credit factors: Liquidity, Leverage, Profitability, and Size, to provide credit/liquidity analysis for over 370 public Cannabis/Hemp companies.

Weekly Credit Report The Lease vs Loan Decision

  • The Pharmacann/IIPR saga led us to reflect on the capital structure decision that MSOs face: take on long-term sales leasebacks or borrow secured debt against the real estate. Each choice has its advantages:
  • LEASE ADVANTAGES:
    • A more permanent solution. Sale leasebacks have extended terms of over 15 years. Having this money locked up allows the MSO to concentrate on its operations without the distractions of having to roll shorter-term financing more frequently. A number of MSOs have significant debt maturities in 2026, and unfortunately, those maturities coincide with a period of subpar growth and profitability. When you have to roll your debt every 3-5 years, you take the risk of going through a trough in earnings at the time of the roll.
    • Higher LTV – Sale leasebacks often cover the entire value of the real estate and may even provide for tenant improvements. This amounts to over 100% loan-to-value. A company borrowing against the same real estate may only get 70% LTV and then have to finance the building improvements as well. For this reason, the apparent cost advantage of borrowing is often illusory by the time you account for the mezzanine debt and/or additional equity required.
    • Leases often contain fewer maintenance covenants that restrict corporate operations.
  • DEBT ADVANTAGES:
    • More flexibility: A shorter-term loan secured by real estate and corporate value can be prepaid or refinanced much more readily. If the company’s credit quality improves dramatically or market lending conditions improve, there may be an opportunity to refinance at lower rates and better terms. We were advising clients to focus on prepayment terms because we anticipated a rescheduling-driven opportunity to sell equity and reduce leverage. We all know what happened there!
    • Sales leaseback agreements often contain automatic 3% rent escalators that, over time, can make the lease less affordable. The lessor may have less flexibility in responding to tenant needs for cash flow relief. We are seeing this drama play out with Pharmacann / IIPR right now. IIPR might be willing to grant some reductions in rental rates to Pharmacann because the alternative of having to release a substantial portion of IIPR’s portfolio at a time when asset values are depressed is not a pleasant one. Failure to release the properties fairly quickly could cause the company to reduce its dividends. However, IIPR has to be concerned that if it grants rental reductions to Pharmacann, a slew of other tenants will be lined up at the door.
  • WHAT CHOICES ARE MSOs MAKING?
    • The chart below shows the debt structure of 15 MSOs. The blue bars represent the percentage of the debt + lease total that is debt. The orange bars represent the lease percentage of the mix.
    • There are clearly vast differences in the choices the MSOs are making. Some companies, like Glass House and Vext, have less than 10% of their debt in leases, while others, like Ascend, Green Thumb, and Planet 13, have 50% or more of their debt represented by leases.
    • Investors need to be cognizant of the tradeoffs. For companies with debt-heavy structures, investors need to be concerned about refinancing risk. For lease-heavy structures, investors need to consider whether the escalated lease rates are restricting company profitability.

Credit Tracker By Sector

Credit ratings are not currently available for public cannabis companies leaving companies, lenders and investors with a gap of information. The Viridian Cannabis Credit Tracker fills this gap. The model uses 11 market and financial statement variables to discern 4 key credit factors: Liquidity, Leverage, Profitability, and Size, to provide credit/liquidity analysis for over 370 public Cannabis/Hemp companies.

Weekly Sector Credit Cultivation & Retail

    • The median total liabilities to market cap of cultivation and retail sector companies jumped to 2.29x times from last week’s reading of 2.09x, implying approximately 1.24x asset value coverage of liabilities according to our option model.
    • Somwhat less favorable is the .25x median value of 2025 EBITDAR to Adjusted Liabilities. The reciprocal of this ratio – 4x is the debt to ebitdar ratio taking into account leases and tax debt. This is still an unsustainable level in a 280e environment, which implies the clock is ticking and we are likely to see increasing signs of credit stress if no progress in made in Washington D.C.

Weekly Sector Credit Cultivation & Retail

    • The median total liabilities to market cap of cultivation and retail sector companies jumped to 2.29x times from last week’s reading of 2.09x, implying approximately 1.24x asset value coverage of liabilities according to our option model.
    • Somwhat less favorable is the .25x median value of 2025 EBITDAR to Adjusted Liabilities. The reciprocal of this ratio – 4x is the debt to ebitdar ratio taking into account leases and tax debt. This is still an unsustainable level in a 280e environment, which implies the clock is ticking and we are likely to see increasing signs of credit stress if no progress in made in Washington D.C.

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.